-
Posted by
Two Blokes Apr 28 -
Filed in
Stock
-
3 views
The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide list price for new medicines is "deeply flawed" and would not solve global pricing inequities.
